WebApr 10, 2024 · ColoAlert Revenue Increases 130% Year over Year. Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection … WebJan 3, 2024 · Throughout 2024, Mainz Biomed operated in a position of financial strength, having successfully executed a USD 25.8 million public follow-on offering in January, which consisted of 1,725,000 ordinary shares priced at USD 15.00 per share. During the year, to keep pace with product development and commercial growth, the Company made it a …
Mainz Biomed Provides Full Year 2024 Financial Results - Yahoo …
WebApr 10, 2024 · Mainz Biomed macht 2024 einen Umsatz von 0,53 Millionen Dollar, im Vorjahr waren es 0,58 Millionen Dollar. Die F&E-Ausgaben steigen von 0,47 Millionen Dollar auf 3,66 Millionen Dollar an. Die WebMar 7, 2024 · At Mainz BioMed, every day is about making a difference in the lives of people around the world. ... Mainz, Germany. Posted: March 1, 2024. READ MORE >> DOWNLOAD PRESENTATION +49 (0) 6131 / 55428-60; Visit LinkedIn; Visit Twitter; Visit Facebook +49 (0) 6131 / 55428-60; fhcl3010
Mainz Biomed Launches Number of Educational Events in
WebAug 16, 2024 · About Mainz Biomed N.V. Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert, an accurate, non ... WebApr 10, 2024 · Early identification of Cancer saves lives. To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products … OUR BUSINESS CONCEPT & PIPELINE SAVES LIVES AND HEALTH CARE … COLOALERT TARGET CONDITION COLORECTAL CANCER 37 … Mainz BioMed is developing proprietary genetic testing methods for pancreatic … NEWS English / EnglischGerman / Deutsch All Corporate News All All Corporate … CONTACT CONTACT US To contact us send us a message using the form or … CAREERS CAREERS At Mainz BioMed, every day is about making a difference … WebApr 10, 2024 · MYNZ +2.20% + Free Alerts. ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today financial results for the ... fhcl 2018